Today
-0.66%
5 Days
-1.40%
1 Month
+0.48%
6 Months
-11.83%
Year to Date
-1.19%
1 Year
-2.18%
• Tyson lowered fiscal 2026 revenue and adjusted operating income guidance. • Severe U.S. cattle shortages and high procurement costs squeezed beef margins. • Technical indicators show bearish signals with an RSI of 29.518.
• Monster Beverage completed a two-for-one stock split reducing nominal share prices. • Second-quarter revenue and adjusted earnings per share exceeded consensus analyst estimates. • Technical indicators show oversold conditions with a MACD sell signal.
• Profit-taking and heavy promotional spend caused downward momentum and margin scrutiny. • Regional performance disparities and soft Asian markets pressured overall volume recovery. • Technical indicators showed neutral conditions while analysts maintained Buy ratings.
• FDA discourse regarding potential nicotine caps creates significant regulatory uncertainty for Altria. • Rising Treasury yields reduce the attractiveness of Altria’s dividend relative to fixed-income investments. • Competitive pressure in smoke-free segments and persistent inflation dampen investor confidence in growth.
• Regulatory restrictions on nicotine products challenge British American Tobacco's New Categories revenue growth projections. • Higher interest rates and inflation reduce the appeal of the company's dividend-focused stock. • Market share erosion in U.S. vapor markets contributes to increased selling pressure and volatility.
• Premium spirits growth and normalized inventory levels drove Diageo's recent financial recovery. • Strategic pricing and supply chain optimizations have successfully mitigated input cost inflation. • Diageo reports $20.25 billion in annual revenue with analysts setting positive price targets.


| Shareholders | Proportion |
|---|---|
| Vanguard Capital Management, LLC | 6.50% |
| BlackRock Institutional Trust Company, N.A. | 5.42% |
| State Street Investment Management (US) | 4.35% |
| Vanguard Portfolio Management, LLC | 2.67% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 44.69% |
| Investment Advisor/Hedge Fund | 21.82% |
| Research Firm | 4.34% |
| Bank and Trust | 2.54% |
Related Instruments
Popular Instruments